Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


01.05.2017

1 Am J Gastroenterol
2 Ann Intern Med
1 Clin Res Hepatol Gastroenterol
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
4 J Hepatol
1 J Viral Hepat
3 J Virol
2 Lancet Gastroenterol Hepatol
1 Lancet Infect Dis
2 PLoS One
2 Transplant Proc
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    Ann Intern Med

  2. BERSOFF-MATCHA SJ, Cao K, Jason M, Ajao A, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M17-0377.
    PubMed     Text format     Abstract available

  3. TALAL AH, Thomas DL, Reynolds JL, Khalsa JH, et al
    Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M16-2887.
    PubMed     Text format    


    Clin Res Hepatol Gastroenterol

  4. TARAMASSO L, Ricci E, Celesia BM, Bonfanti P, et al
    Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
    Clin Res Hepatol Gastroenterol. 2017 Apr 21. pii: S2210-7401(17)30085.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  5. CORDERO-RUIZ P, Carmona-Soria I, Rodriguez-Tellez M, Caunedo-Alvarez A, et al
    Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.
    Eur J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1097/MEG.0000000000000886.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. KANWAL F, Bacon BR, Beste LA, Brill JV, et al
    Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
    Gastroenterology. 2017;152:1588-1598.
    PubMed     Text format    


    J Hepatol

  7. BRUNO S, Maisonneuve P
    Response to the letter regarding the manuscript "Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population".
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30216.
    PubMed     Text format    

  8. BANKWITZ D, Doepke M, Hueging K, Weller R, et al
    Maturation of secreted HCV particles by incorporation of secreted apoE protects from antibodies by enhancing infectivity.
    J Hepatol. 2017 Apr 21. pii: S0168-8278(17)30251.
    PubMed     Text format     Abstract available

  9. HALLAGER S, Ladelund S, Weis N
    Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment.
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30218.
    PubMed     Text format    

  10. KAWAGISHI N, Suda G, Onozawa M, Kimura M, et al
    Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection.
    J Hepatol. 2017 Apr 21. pii: S0168-8278(17)30249.
    PubMed     Text format     Abstract available


    J Viral Hepat

  11. STEININGER K, Boyd A, Dupke S, Krznaric I, et al
    HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.
    J Viral Hepat. 2017 Apr 25. doi: 10.1111/jvh.12707.
    PubMed     Text format     Abstract available


    J Virol

  12. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Text format     Abstract available

  13. WALTER S, Bollenbach A, Doerrbecker J, Pfaender S, et al
    Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
    J Virol. 2016;90:5075-89.
    PubMed     Text format     Abstract available

  14. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  15. GREBELY J, Lamoury FMJ, Hajarizadeh B, Mowat Y, et al
    Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study.
    Lancet Gastroenterol Hepatol. 2017 Apr 21. pii: S2468-1253(17)30075.
    PubMed     Text format     Abstract available

  16. COOPER C
    Rapid HCV RNA testing: removing the final obstacle to elimination.
    Lancet Gastroenterol Hepatol. 2017 Apr 21. pii: S2468-1253(17)30086.
    PubMed     Text format    


    Lancet Infect Dis

  17. YU ML
    Short duration of direct-acting antivirals for acute HCV infection.
    Lancet Infect Dis. 2017;17:481-482.
    PubMed     Text format    


    PLoS One

  18. CAPILENO YA, Van den Bergh R, Donchunk D, Hinderaker SG, et al
    Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    PLoS One. 2017;12:e0175562.
    PubMed     Text format     Abstract available

  19. PENE V, Lemasson M, Harper F, Pierron G, et al
    Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis.
    PLoS One. 2017;12:e0175810.
    PubMed     Text format     Abstract available


    Transplant Proc

  20. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
    Transplant Proc. 2016;48:1341-6.
    PubMed     Text format     Abstract available

  21. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.
    Transplant Proc. 2016;48:1347-9.
    PubMed     Text format     Abstract available


    Transplantation

  22. SINGH N, Dies D, Samant H
    Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Transplantation. 2017;101:e192.
    PubMed     Text format    

  23. TERRAULT NA, Berenguer M, Strasser SI, Gadano A, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Transplantation. 2017;101:956-967.
    PubMed     Text format    

  24. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Transplantation. 2017;101:945-955.
    PubMed     Text format    

  25. TAPPER EB, Afdhal NH, Curry MP
    Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.
    Transplantation. 2017;101:933-937.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: